US Patent Issued to GENEXINE, HANDOK on Sept. 30 for "Method for treating growth hormone deficiency employing hGH fusion protein" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,186, issued on Sept. 30, was assigned to GENEXINE INC. (Seongnam-si, South Korea) and HANDOK INC. (Seoul, South Korea).

"Method for treating growth hormone deficiency employing hGH fusion protein" was invented by Tae Kyung Kim (Seongnam-si, South Korea), Jung Won Woo (Seoul, South Korea), Joan Yoon Ji Lee (Seongnam-si, South Korea), Young-Joo Ahn (Seongnam-si, South Korea), Ji-Eun Cha (Seongnam-si, South Korea), Hyou Young Rhim (Gwacheon-si, South Korea) and Woo Ick Jang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for treating growth hormone deficiency, including administering a human growth hormone fusion protein (G...